Impact of Preoperative Radiation Boost on Oncotype DX® Result in a Phase II Clinical Trial.
Saved in:
| Title: | Impact of Preoperative Radiation Boost on Oncotype DX® Result in a Phase II Clinical Trial. |
|---|---|
| Authors: | Eladoumikdachi F; Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA., Chakraborty MA; Rutgers New Jersey Medical School, Newark, NJ, USA., Ohri N; Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA., Kowzun M; Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA., Kumar S; Division of Surgical Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA., Toppmeyer D; Division of Medical Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA., Haffty BG; Department of Radiation Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA. hafftybg@cinj.rutgers.edu. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2025 Jul 09. Date of Electronic Publication: 2025 Jul 09. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
